Introduction
============

Major depressive disorder (MDD), which is one of the most common mental disorders, is the leading cause of disability worldwide and a major contributor to the global burden of disease ([@nsx100-B20]). With the progress of the disease, the severely depressed patients may have suicide attempt or even commit suicide. Given the slow effect of medication, electroconvulsive therapy (ECT), which is a rapid and effective way to alleviate the disease symptoms, has been widely used to treat the severe depression patients who have not responded to multiple medication trials or who are at imminent risk of suicide ([@nsx100-B38]; [@nsx100-B36]). However, the neural basis of the ECT relieving symptoms of depression is still largely unknown.

There are several theories were proposed to illuminate the mechanisms of ECT ([@nsx100-B36]). An increasing number of **studies** has suggested that the antidepressant effect results from ECT mediating neuroplasticity which induced increased rates of neurogenesis, synaptogenesis and glial proliferation ([@nsx100-B39]; [@nsx100-B46]; [@nsx100-B54]; [@nsx100-B13]; [@nsx100-B49]). Modern structural magnetic resonance imaging (sMRI) technique has identified the structural changes in frontal and medial temporal cortex ([@nsx100-B16]; [@nsx100-B32]). However, only assessing the structural changes cannot inform the abnormal functional connectivity patterns with other brain areas, which actually determines the functions of a brain area ([@nsx100-B47]). Recently, resting-state functional connectivity (RSFC) analysis has been adopted to reveal the functional networks' changes after ECT. [@nsx100-B48] found that the average global functional connectivity was decreased in the left dorsolateral prefrontal cortex (dlPFC) after ECT. Subsequently, [@nsx100-B1] identified a significantly increased pattern of functional network connectivity between the posterior default mode network and the left dlPFC in ECT remitters compared with ECT non-remitters. The discrepancy of these findings among different studies raises the question what's the exact role of ECT on alleviating symptoms of depression.

In this study, we aimed to uncover the possible neurophysiological basis of ECT using structural and resting-state functional MRI (rs-fMRI). The sMRI was used to characterize the changes of brain gray matter volume (GMV), whereas the rs-fMRI was used to reveal the changed functional networks. rs-fMRI, which predominantly reflects the spontaneous brain functional activities related to self-initiated behavior ([@nsx100-B21]), could better characterize the changes of the intrinsic functional connectivity patterns. However, RSFC cannot identify the causal effects between brain areas, thus, Granger causality analysis (GCA) was additionally applied to reveal the causal interactions between brain areas. Because of the lag between hemodynamic response function (HRF) and sampling rate of fMRI data, the inhibitory and excitatory nature of neuronal clusters and the size of neuronal cluster activation can diminish the ability to correctly identify causality across the brain. However, although GCA of fMRI data is still controversial, emerging reports have demonstrated that GCA can effectively identify the directed functional interactions between brain areas ([@nsx100-B58]; [@nsx100-B27]). Finally, multivariate pattern analysis using linear support vector machine (SVM) was employed to test whether these altered neural indices can serve as biomarkers for diagnosing MDD.

Materials and methods
=====================

Participants
------------

Twenty-three MDD patients participating in ECT treatment were recruited in the Anhui Mental Health Center in Anhui province of China. Parts of participants' fMRI data were used in a previous study ([@nsx100-B60]). Diagnosis of a MDD was evaluated by a trained senior psychiatrist Xiaoqin Zhou (XQZ) based on Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria. Patients with a treatment-resistant MDD or with acute suicidal tendencies were assigned to ECT. Exclusion criteria for this study were **substance use disorder**, pregnancy, life threatening somatic disease, neurological disorders, other comorbid mental disorders, previous ECT treatment as well as MRI-contraindications. Finally, a total of 23 participants (11 males and 12 females, **range** from 18 to 55 years, mean age = 38.74 years, s.d. = 11.02; mean education level = 8.83 years, s.d. = 3.89) were enrolled in this study. All patients continued to take antidepressive medication during the course of the study (details presented in [Table 1](#nsx100-T1){ref-type="table"}). The severity of depression was assessed using the 17-item Hamilton Rating Scale for Depression (HRSD) ([@nsx100-B28]). The scale was administered 12--24 h before the first ECT and 24--72 h after the last ECT. The antidepressive ECT treatment response was evaluated using a paired two-sided *t*-test on the HRSD scores, and the threshold for significance was set at *P* \< 0.05. As a reference group 25 gender, age and education matched healthy controls (HC) (12 males and 13 females, range from 26 to 51 years, mean age = 39.52 years, s.d. = 8.07; mean education level = 8.84 years, s.d. = 3.05) were included in this study. All participants were right-handed and provided written informed consent. The study was in accordance with the latest revision of the declaration of Helsinki and experimental procedures and had full ethical approval from the local ethics committees of the Anhui Medical University (**ethics committee reference number: 20140072**). Table 1.Demographic and clinical variablesSubjectsMDDHealthy controls*P* valueNumber of subjects2325Age (mean ± s.d.)38.74 ± 11.0239.52 ± 8.070.7794Gender (male/female)11/1212/130.9904Education level (mean ± s.d.)8.83 ± 3.898.84 ± 3.050.9890HRSD scores (mean ± s.d.) Before ECT22.22 ± 4.74 After ECT3.83 ± 2.15Number of treatment (mean ± s.d.)7.26 ± 2Age of onset (years)33.90 ± 12.26Durations of illness (months)70.35 ± 83.27Episodes (*n* patients) First8 Recurrence15Family history (*n* patients)2Medication (*n* patients)23Medication-free0On-medication23 SSRIs7 SNRIs4 SSRIs + SNRIs1 SSRIs + NaSSAs1 SSRIs + SARIs1 SSRIs + antipsychotics9[^2]

ECT procedures
--------------

Patients underwent a modified bifrontal ECT protocol using a Thymatron System IV Integrated ECT System (Somatics, Lake Bluff, IL) in the Anhui Mental Health Center. The first three ECT sessions were administered on consecutive days, and the subsequent ECT sessions were conducted every other day with a break over the weekends until patients' reached symptom remission. The initial percent energy dial was set based on the age of each participant (e.g. 50% for a 50-year-old patient). The stimulation strength can be evenly adjusted with an increment of 5% of the maximum charge. The maximum stimulus charge is ∼1000 mC (millicoulomb) in our treatment strategy (Thymatron 2× instrument). If no seizure activity was detected with the initial stimulation setting, the percent energy was increased until seizure was visually observed. The ECT procedure was administered under propofol anesthesia. Succinylcholine and atropine were additionally administered to relax the musculature and suppress the secretion of glands. Seizure activity was additionally monitored via electroencephalography ([@nsx100-B60]).

MRI data acquisition
--------------------

All MRI data were acquired on a clinical 3.0 T whole-body MRI system (Signa HDxt, GE Healthcare, Buckinghamshire, UK) at the First Affiliated Hospital of Anhui Medical University in Anhui province of China. Patients were scanned 12--24 h before the first ECT and 24--72 h after the last ECT. To determine pre-treatment neural alterations in the patients, HC were scanned once. Participants were instructed to relax and to keep their eyes closed, to remain awake and not to think of anything during the MRI acquisition. T1-weighted anatomic images were acquired in sagittal orientation with three-dimensional inversion recovery prepared fast spoiled gradient recalled sequence (repetition time/echo time ratio = 8.676/3.184 ms, inversion time = 800 ms, flip angle = 8°, field of view = 256 × 256 mm^2^, matrix size = 256 × 256, slice thickness = 1 mm, voxel size = 1 × 1 × 1 mm^3^, sections = 188). The resting-state functional images were acquired using a standard echo planar imaging (EPI) sequence (repetition time/echo time ratio = 2000/22.5 ms, 240 volumes, flip angle = 30°, 33 slices, thickness/gap = 4.0/0.6 mm, voxel size = 3.4 × 3.4 × 4.6 mm^3^, matrix size = 64 × 64, field of view = 220 × 220 mm^2^).

VBM analyses
------------

Voxel-based morphology (VBM) analyses were performed to determine brain structural changes before and after ECT in the MDD patients as well as to determine pre-treatment differences between patients and controls. The sMRI images were preprocessed using VBM8 toolbox (<http://dbm.neuro.uni-jena.de/vbm.html>) in SPM8 (Statistical Parametric Mapping software: <http://www.fil.ion.ucl.ac.uk/spm>). The modulated VBM8 were used to calculate the GMV and were corrected for total intracranial volume. In this study, we used the longitudinal VBM analyses of the sMRI data before and after ECT. Within-subject midway coregistration was performed to account for between-session variance. Each structural image was segmented into gray matter, white matter and cerebrospinal fluid using a fully automated algorithm within SPM8 and subsequently transformed to Montreal Neurological Institute (MNI) space using Diffeomorphic anatomical registration through exponentiated Lie algebra (DARTEL)-normalization. Next, the normalized gray matter images were smoothed for statistical analyses ([@nsx100-B4]). Finally, a paired *t*-test (whole brain volume as covariant) was performed on these normalized GMV maps to determine brain regions with significant pre--post-treatment differences. Voxel-wise family wise error (FWE) correction was used for multicomparison correction to control type 1 error (*P* \< 0.05, FWE corrected, minimum cluster size ≥ 30 voxels). To control the effects of different Gaussian smoothing kernels, we used Gaussian kernels with different full-width at half-maximum (FWHM = 4, 6, 8 and 10) to smooth the normalized gray matter images for the subsequent statistical analyses. Next, the overlap between the results obtained under different smooth kernels was reported as final result. Finally, the overlapping results from the different smoothing kernels were used as seed region for the subsequent functional connectivity analyses. For the cross-sectional comparison between pre-treatment brain structural differences between patients and controls, standard VBM procedures were employed to calculate the HC participants' GMV. Next, we extracted the mean GMV of the brain regions with changed GMV after ECT. Then, two-sample *t*-test was performed between the HC and pre-treatment of MDD patients and significant level was set at *P* \<0.05.

Localization of brain structural changes
----------------------------------------

To determine the exact anatomical location of significant differences in GMV, results were mapped using cytoarchitectonical maps, allowing to determine probabilistic localization within subregions of the amygdala including the superficial (SF) subregion, centromedial (CM) subregion and laterobasal (LB) subregion as provided within the Anatomy toolbox ([@nsx100-B17]).

rs-fMRI data preprocessing
--------------------------

The preprocessing of the rs-fMRI data were carried out using SPM8 software. The first 10 volumes were discarded to allow for magnetization equilibrium. The slice timing for the remaining images was corrected, and images were realigned to the first volume to account for head motion. All participants showed a maximum displacement of \< 3 mm and an angular motion of \< 3° and thus were included in the subsequent analyses. All fMRI images were normalized to MNI EPI template and resampled at 3 × 3 × 3 mm^3^. Finally, the functional images were smoothed using a Gaussian kernel of 6 mm FWHM. Subsequently, the functional images were filtered with a temporal band-path of 0.01--0.1 Hz and six motion parameters, white matter and cerebrospinal fluid signals were regressed out. Because previous studies have shown that global mean signal regression can lead to spurious resting-state functional correlations and false inferences, particularly on the group level inference ([@nsx100-B25]; [@nsx100-B53]), the global mean signal was not regressed during the preprocessing in this study.

RSFC analyses
-------------

To identify whether ECT changed the functional interplay of regions displaying significant GMV changes during ECT treatment, whole brain RSFC, which is defined by the Pearson correlation between the time series, was computed using clusters with significant GMV changes during treatment as seed region. To calculate the RSFC, we first resampled the brain areas identified in VBM analyses to 3 mm cubic voxels in MNI space. The Pearson correlation coefficients between the mean time series for each seed region and the mean time series for each voxel of the whole brain were next calculated for each subject and then converted to *z* values using Fisher's *z* transformation to improve normality. On the group level, each individual's *z* values were entered into a paired *t*-test (head motion parameters as covariant) in a voxel-wise manner to determine the regions that showed significantly different connectivity to the seed region. Significance was determined using a cluster-level Monte Carlo simulation (5000 times) corrected threshold of *P* \< 0.05 (cluster-forming threshold at voxel-level *P* \< 0.001).

Meta-analysis to define FFA
---------------------------

To determine whether the areas showing functional changes corresponded to the fusiform face area (FFA), a meta-analytic method was used to define the anatomical location of the FFA using the BrainMap database ([www.brainmap.org](http://www.brainmap.org)). For the meta-analytic approach only task-based fMRI studies in healthy participants that reported functional mapping experiments using face monitor/discrimination paradigms were included. In addition, only the experiments reported activation were included. We excluded the studies **in** patient population or specifically examining gender differences. No further constraints were enforced. According to these criteria, 118 articles with 394 experiments were included and the corresponding coordinate files were downloaded. Next, we performed activation likelihood estimation (ALE) in standard MNI space using, and the resultant ALE map was corrected using false discovery rate (FDR) *P *\< 0.01 with minimum volume = 200 mm^3^. After **obtaining** the FFA, we mapped the functionally changed area to the FFA to determine the correspondence between the two regions.

GCA of ECT-induced brain functional changes
-------------------------------------------

GCA was performed to further explore the causal interaction between brain areas with functional connectivity changes before and after ECT. GCA was performed using the Causal Connectivity Toolbox ([@nsx100-B55]). We first extracted the mean time series of the brain areas determined by RSFC analyses. Then, the bivariate GCA was performed on the time series to test the causal interactions. The order of the autoregressive model used for computation of the influence measure was selected using the Bayesian information criterion and magnitudes of causal interactions were obtained. Finally, a paired *t*-test was performed on the magnitudes of causal interactions to identify the significantly causal influences between brain areas using a significance threshold of *P *\< 0.05.

Multivariate pattern analysis using SVM
---------------------------------------

To explore whether the identified neural indices might serve as biomarkers for diagnosing MDD, a linear SVM approach within a library for SVMs (LIBSVMs) toolkit running on MATLAB ([@nsx100-B12]) was performed. The mean regional GMV of amygdala, functional connectivity between amygdala and FFA, and effective connectivity from FFA to amygdala were used as the features for classification. We used a leave-one-out cross-validation strategy because of our limited number of samples to estimate the generalization ability of our classifier. The performance of a classifier was assessed using the classification accuracy, sensitivity and specificity based on the results of the cross-validation.

Functional characterization with BrainMap database
--------------------------------------------------

To determine the functional roles of the brain regions showing ECT-associated changes, a behavioral characterization using the BrainMap database was performed. The behavioral domains were determined by examining which types of tasks were significantly associated with the identified regions. The behavioral domain analysis included 5 behavioral domains and 51 behavioral subdomains. Functional characterization of the regions showing ECT-associated structural and functional changes was determined using forward inferences ([@nsx100-B9]). The significance was established using a binomial test (*P *\< 0.05) corrected for multiple comparisons using FDR.

Correlation analysis
--------------------

We performed correlation analysis between each subject's mean GMV, functional connectivity strength and the causal connectivity strength and the HRSD scores to further explore whether neuroimaging indices were related to changes on the symptom-level. The significance level was set at *P* \< 0.05.

Results
=======

Demographic and clinical characteristics
----------------------------------------

There were no significant differences in age (*P *= 0.7794), gender (*P *= 0.9904) and education level (*P *= 0.9890) between MDD and HC groups ([Table 1](#nsx100-T1){ref-type="table"}). Within the group of MDD patients' depressive symptom load as assessed by the HRSD significantly decreased during the course of ECT treatment ([Figure 1](#nsx100-F1){ref-type="fig"}).

![Mood scores before and after ECT. HRSD was used to assess the level of depression before and after ECT. The mean and SEM HRSD score were shown. A paired two-sided *t*-test was performed, and a threshold value was set at *P* \< 0.05 for significance.](nsx100f1){#nsx100-F1}

GMV changes
-----------

The VBM analyses consistently identified increased amygdala GMV following ECT in different smooth kernels ([Figure 2A](#nsx100-F2){ref-type="fig"}). The overlap of the results obtained with different smooth kernels was found to be located in the left amygdala \[MNI central coordinates (−13.5, −6, −22.5), cluster size: 49 voxel with resolution 1.5 × 1.5 × 1.5 mm^3^\] ([Figure 2B](#nsx100-F2){ref-type="fig"}), especially in the left SF amygdala ([Figure 2C](#nsx100-F2){ref-type="fig"}). In addition, compared with HC group, patients with MDD also showed reduced left SF amygdala volume ([Figure 2D](#nsx100-F2){ref-type="fig"}).

![Longitudinal effect of ECT on amygdala volume. (A) VBM was used to detect the changed GMV. The GMV was smoothed using Gaussian kernels with different FWHM (FWHM = 4, 6, 8 and 10) to identify the consistently changed GMV across different smooth kernels to exclude the effects of different smooth kernels. The whole brain voxel-wise paired *t*-test was used to identify the changed GMV, and FWE method with minimum 30 voxels was used for multicomparison correction (*P *\< 0.05, FWE corrected). (B) The consistently increased GMV of left amygdala after ECT was identified by calculating the overlap across different smooth kernels. (C) The changed GMV region was localized by overlapping with the cytoarchitectonic subregions of amygdala including SF amygdala, CM amygdala and LB amygdala. The altered GMV brain area was mainly located on the SF amygdala. (D) The mean GMV of SF amygdala in HC, before ECT and after ECT was calculated. The significantly decreased GMV in MDD patients was identified compared with HC or after ECT. \*\*\**P* \< 0.001.](nsx100f2){#nsx100-F2}

Changed functional connectivity
-------------------------------

Whole brain RSFC analyses identified enhanced functional connectivity strength between the left SF amygdala and left posterior fusiform gyrus in MDD patients after ECT ([Figure 3A](#nsx100-F3){ref-type="fig"}). Subsequently, we used meta-analysis to define the exact anatomical location of the FFA ([Figure 3B](#nsx100-F3){ref-type="fig"}) and found a high overlap between the FFA and the identified region showing ECT-induced connectivity changes ([Figure 3C](#nsx100-F3){ref-type="fig"}). In addition, we found that MDD patients showed decreased functional connectivity between the left SF amygdala and FFA as compared with HC ([Figure 3D](#nsx100-F3){ref-type="fig"}).

![RSFC analyses of SF subregion of amygdala. (A) Whole brain RSFC analysis of SF subregion was performed, and paired *t*-test was used to reveal the changes of FC. A cluster-level Monte Carlo simulation (5000 times) corrected threshold of *P* \< 0.05 was used to identify the significant changes in FC (cluster-forming threshold at voxel-level *P* \< 0.001). (B) We used meta-analysis in BrainMap database to define the exact anatomical location of FFA. (C) We overlaid the functionally changed brain area onto the FFA defined using meta-analysis and found the functionally changed brain area was completely overlapped with FFA. (D) The mean FC strength between SF amygdala and FFA in HC, before ECT and after ECT was calculated. The decreased FC in MDD patients was identified. \**P* \< 0.05.](nsx100f3){#nsx100-F3}

GCA results
-----------

To further determine the causal direction of the effects, a GCA was performed and identified a significant increased magnitude of causal interactions from FFA to amygdala after ECT (*P* \< 0.05) ([Figure 4](#nsx100-F4){ref-type="fig"}). The GCA result indicated that the increased functional connectivity between amygdala and FFA was driven by increasing effects of the FFA on the amygdala.

![Effective connectivity between SF amygdala and FFA. GCA was used to calculate the effective connectivity between FFA and SF amygdala in HC, before ECT and after ECT. GCA identified significantly enhanced effective connectivity from FFA to SF amygdala after ECT. Compared with HC, MDD patients showed decreased effective connectivity from FFA to SF amygdala. \**P* \< 0.05.](nsx100f4){#nsx100-F4}

Classification results
----------------------

Using the combined features of GMV, RSFC and effective connectivity, the linear SVM classifier achieved an accuracy of 83.33% \[82.61% for MDD patients (sensitivity), 84% for HC (specificity)\] ([Figure 5](#nsx100-F5){ref-type="fig"}).

![Multivariate pattern analysis using LIBSVM was applied to provide provisional evidence to determine whether identified neural indices might serve as biomarkers for diagnosing MDD. The regional GMV of amygdala, FC between SF amygdala and FFA and effective connectivity from FFA to SF amygdala were used as the features for classification. We used a leave-one-out cross-validation strategy to estimate the generalization ability of our classifier. The classification accuracy, sensitivity and specificity were showed.](nsx100f5){#nsx100-F5}

Correlation analyses
--------------------

Correlation analyses **revealed** that mean GMV in SF amygdala and functional connectivity between SF amygdala and FFA were significantly correlated to symptoms of depression before ECT ([Figure 6](#nsx100-F6){ref-type="fig"}), which further suggested a direct association between these alterations and depression symptomatology.

![Correlation analyses between the altered neural indices and HRSD scores. Correlation analyses between the HRSD scores and mean GMV of SF amygdala, mean FC strength between SF amygdala and FFA, mean effective connectivity strength from FFA to SF amygdala were separately performed before and after ECT. The significant correlation between HRSD scores and mean GMV of SF amygdala and mean FC strength before ECT was identified. The significant level was set at *P* \< 0.05.](nsx100f6){#nsx100-F6}

Meta-analysis based functional characterization
-----------------------------------------------

Behavioral characterization identified a significant association of the left SF amygdala and FFA with cognition memory, visual perception, disgust and fear emotion processing and semantic processing ([Figure 7](#nsx100-F7){ref-type="fig"}).

![Behavioral characterization of the significant brain areas of SF amygdala and FFA. Only behavioral domains significantly associated with the FFA and SF amygdala at *P* \< 0.05 (FDR corrected) are shown.](nsx100f7){#nsx100-F7}

Discussion
==========

The goal of this study was to explore the possible neuroanatomical basis of ECT improving the clinical response in MDD patients with an average of 2--3 weeks treatment from the first to the last ECT session by establishing the structural and functional changes. VBM and connectivity analyses identified increased GMV of SF nucleus of amygdala, increased RSFC between SF amygdala and FFA and enhanced effective connectivity from FFA to SF amygdala after ECT. Multivariate pattern analysis using linear SVM further demonstrated that these neuroimaging indices can **serve** as a biomarker for diagnosing MDD. These findings indicated that ECT may enhance the neurogenesis of amygdala and the feedforward connection from cortical FFA to subcortical area of SF amygdala to improve the social information processing, early conscious perception of emotion and assessing emotion valence and emotional memory processing in MDD patients.

SF nucleus of amygdala
----------------------

Amygdala is the core structure for processing of emotion ([@nsx100-B62]), especially for fear processing ([@nsx100-B44]), in the brain. Recent studies have indicated that amygdala is a very complex structure composed of a heterogenous group of nuclei and subnuclei, which have distinct cytoarchitectonics ([@nsx100-B3]), functional ([@nsx100-B50]; [@nsx100-B9]; [@nsx100-B42]) and anatomical connectivity patterns ([@nsx100-B5]). Our current findings revealed that ECT mainly increased the volume of the left SF nucleus of amygdala, which was traditionally thought to be exclusively involved in olfactory perception and olfactory-related affective processing ([@nsx100-B43]; [@nsx100-B9]). An increasing number of neuroimaging evidence has suggested that the SF nucleus of amygdala also participated in multiple emotion processing and social information processing ([@nsx100-B2]; [@nsx100-B31]), and the activity of the SF amygdala can be predicted by the activity of the connected limbic lobe which is the core network for emotion processing ([@nsx100-B52]). Recently, using *invivo* task fMRI, [@nsx100-B24] directly demonstrated that SF amygdala selectively extracts the social value of incoming stimuli in human. Therefore, increased GMV of SF amygdala suggested that ECT can improve the emotion processing and social behavior in depression patients. The increased GMV of left amygdala identified in this study was supported by the previous studies which also found increased volume of the left amygdala after ECT ([@nsx100-B22]; [@nsx100-B16]; [@nsx100-B32]) and decreased volume of the amygdala in MDD compared with the HC ([@nsx100-B59]; [@nsx100-B15]). Using the same VBM method, [@nsx100-B16] identified increased GMV in hippocampus which actually corresponds to the SF amygdala identified in this study. Additionally, compared with Joshi *et al.*' (2016) findings, we only found increased GMV in SF subregion of amygdala, whereas [@nsx100-B32] additionally found the increased volume of the basolateral (LB) nuclei of amygdala. The difference may result from the heterogeneity of MDD patients and the differences in responses of depression patients after ECT. In a word, our findings, together with previous results, indicated that ECT primarily affects the volume of SF nucleus of amygdala, and the increased volume of amygdala may **serve** as a neuroimaging biomarker for the effect of ECT on depression.

Connectivity between FFA and amygdala
-------------------------------------

FFA located on the middle fusiform gyrus, a component of the ventral processing stream for visual information and complex feature detection ([@nsx100-B33]; [@nsx100-B19]), seems to be specifically involved in the perception of faces and recognition of face identity ([@nsx100-B34]; [@nsx100-B40]). Damage to FFA results in visual agnosia and prosopagnosia ([@nsx100-B41]; [@nsx100-B8]). Given an important role of processing of face information in social interaction, the enhanced functional connectivity between FFA and amygdala identified in this study suggested that ECT may alleviate the symptoms of depression by improving the social abilities to enhance the gaze fixation of face stimuli ([@nsx100-B35]; [@nsx100-B14]). This claim was supported by previous studies which revealed that SF nucleus of amygdala exclusively participated in complex social judgments of faces ([@nsx100-B10]) and prosocial value orientation ([@nsx100-B29]). Moreover, many previous studies have demonstrated that amygdala plays a key role in early stage processing of facial expression and modulates the sensory processing via back-projections ([@nsx100-B7]; [@nsx100-B45]; [@nsx100-B62]). However, using GCA, we found enhanced feedforward connection from FFA to SF nucleus of amygdala not the back-projections from SF nucleus to FFA. The functional modulation of FFA on SF was supported by the direct white matter pathway between the two areas ([@nsx100-B11]). Given the fusiform gyrus has been widely reported to take part in processing of novel stimulation for visual features ([@nsx100-B37]; [@nsx100-B57]), our findings thus may indicate that ECT could improve the ability of attention to emotional stimuli to facilitate the early conscious perception of emotion and assessing emotional valence ([@nsx100-B45]; [@nsx100-B26]). The meta-analysis of the SF amygdala and FFA revealed that the two areas were primarily involved in cognitive memory ([Figure 7](#nsx100-F7){ref-type="fig"}). This finding suggested that ECT may also improve the negative emotional or social memory processing in MDD patients ([@nsx100-B51]). In addition, since left FFA was overlapped with the visual word form area (VWFA) ([@nsx100-B63]), therefore, FFA enhancing amygdala early conscious perception of emotion and assessing emotion valence may be achieved by verbal processing of emotion stimuli ([@nsx100-B45]).

ECT mechanism
-------------

There are four main theories were proposed to account for the mechanism of ECT including monoamine neurotransmitter theory, the neuroendocrine theory, the anticonvulsant theory and the neurotrophic theory. The neurotrophic theory which has been widely demonstrated by an increasing number of studies suggests that ECT can induce neurogenesis and increase neurotrophic signaling ([@nsx100-B36]). Animal models investigations have showed that neurotrophic factor decreased in depressive animal and increased after electroconvulsive shock ([@nsx100-B39]; [@nsx100-B30]; [@nsx100-B61]; [@nsx100-B13]; [@nsx100-B49]). Moreover, neurotrophic factor can modulate limbic circuits to promote treatment-related neuroplasticity including synaptogenesis, gliogenesis, angiogenesis and neurogenesis ([@nsx100-B23]; [@nsx100-B18]; [@nsx100-B6]). ECT-mediated neuroplasticity has been replicated in several longitudinal neuroimaging investigations ([@nsx100-B16]; [@nsx100-B32]). In this study, the increased volume of amygdala was found after ECT, which may underlie successful treatment response of depression. Our findings provide the further evidence for the neurotrophic theory of ECT.

Limitations
-----------

There are several limitations in this study. First, the numbers of used patients with ECT is small. The larger samples are needed to further validate this findings. Second, the inhomogeneity of the taken medication is also observed in these MDD patients. Thus, to control the medication effects are needed in future study. Third, we used GCA and identified the causal interaction from FFA to SF amygdala indicating that ECT enhanced the top-down modulation of social and emotion processing. However, because of the technical limitation for fMRI acquisition: (i) the sampling rate for fMRI data is usually much slower than the underlying neuronal responses and (ii) fMRI responses reflect convolution with an HRF imposing long delays with respect to neural activity and, even worse, may have significant interregional variability ([@nsx100-B56]). Given the GCA of fMRI data is still controversial, thus, our findings using GCA need to be demonstrated with other techniques.

Conclusion
==========

We revealed increased GMV in SF nucleus of amygdala, increased functional connectivity between SF amygdala and FFA and effective connectivity from FFA to SF subregion of amygdala in MDD patients. The following multivariate pattern analysis further demonstrated that the identified neural indices can serve as biomarkers for diagnosing MDD. These findings indicated that ECT can increase the neurogenesis of amygdala to improve the symptoms of depression. In addition, this study also suggested that ECT alleviates depression symptoms by enhancing the feedforward connection from FFA to SF amygdala to improve the negative emotional or social memory processing, and early conscious perception of emotion and assessing emotion valance through verb processing to boost the social behavior. Our findings can facilitate future ECT related clinical researches and help to better understand its mechanism and to diagnose the MDD patients.
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